世界の鼻ポリープ治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Nasal Polyps Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5263
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、鼻ポリープ治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬理療法、手術）、用途別市場規模（病院、外来手術センター、専門クリニック）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・鼻ポリープ治療の市場動向
・企業の競争状況、市場シェア
・鼻ポリープ治療の種類別市場規模と予測2016-2027（薬理療法、手術）
・鼻ポリープ治療の用途別市場規模と予測2016-2027（病院、外来手術センター、専門クリニック）
・鼻ポリープ治療の北米市場規模2016-2027（アメリカ、カナダ）
・鼻ポリープ治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・鼻ポリープ治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・鼻ポリープ治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・鼻ポリープ治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（OptiNose US、Regeneron Pharmaceuticals、Merck、Pfizer、F. Hoffmann La-Roche、Intersect ENT、GlaxoSmithKline、Sanofi、Novartis）
・結論

Market Analysis and Insights: Global Nasal Polyps Treatment Market
The global Nasal Polyps Treatment market size is projected to reach US$ 4233.1 million by 2027, from US$ 3377.4 million in 2020, at a CAGR of 2.8% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nasal Polyps Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nasal Polyps Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nasal Polyps Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nasal Polyps Treatment market.

Global Nasal Polyps Treatment Scope and Market Size
Nasal Polyps Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nasal Polyps Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Pharmacological Therapies
Surgeries

Segment by Application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
OptiNose US
Regeneron Pharmaceuticals
Merck
Pfizer
F. Hoffmann La-Roche
Intersect ENT
GlaxoSmithKline
Sanofi
Novartis

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nasal Polyps Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Pharmacological Therapies
1.2.3 Surgeries
1.3 Market by Application
1.3.1 Global Nasal Polyps Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Specialty Clinics
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Nasal Polyps Treatment Market Perspective (2016-2027)
2.2 Nasal Polyps Treatment Growth Trends by Regions
2.2.1 Nasal Polyps Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Nasal Polyps Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Nasal Polyps Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Nasal Polyps Treatment Industry Dynamic
2.3.1 Nasal Polyps Treatment Market Trends
2.3.2 Nasal Polyps Treatment Market Drivers
2.3.3 Nasal Polyps Treatment Market Challenges
2.3.4 Nasal Polyps Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Nasal Polyps Treatment Players by Revenue
3.1.1 Global Top Nasal Polyps Treatment Players by Revenue (2016-2021)
3.1.2 Global Nasal Polyps Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Nasal Polyps Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Nasal Polyps Treatment Revenue
3.4 Global Nasal Polyps Treatment Market Concentration Ratio
3.4.1 Global Nasal Polyps Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nasal Polyps Treatment Revenue in 2020
3.5 Nasal Polyps Treatment Key Players Head office and Area Served
3.6 Key Players Nasal Polyps Treatment Product Solution and Service
3.7 Date of Enter into Nasal Polyps Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Nasal Polyps Treatment Breakdown Data by Type
4.1 Global Nasal Polyps Treatment Historic Market Size by Type (2016-2021)
4.2 Global Nasal Polyps Treatment Forecasted Market Size by Type (2022-2027)

5 Nasal Polyps Treatment Breakdown Data by Application
5.1 Global Nasal Polyps Treatment Historic Market Size by Application (2016-2021)
5.2 Global Nasal Polyps Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Nasal Polyps Treatment Market Size (2016-2027)
6.2 North America Nasal Polyps Treatment Market Size by Type
6.2.1 North America Nasal Polyps Treatment Market Size by Type (2016-2021)
6.2.2 North America Nasal Polyps Treatment Market Size by Type (2022-2027)
6.2.3 North America Nasal Polyps Treatment Market Size by Type (2016-2027)
6.3 North America Nasal Polyps Treatment Market Size by Application
6.3.1 North America Nasal Polyps Treatment Market Size by Application (2016-2021)
6.3.2 North America Nasal Polyps Treatment Market Size by Application (2022-2027)
6.3.3 North America Nasal Polyps Treatment Market Size by Application (2016-2027)
6.4 North America Nasal Polyps Treatment Market Size by Country
6.4.1 North America Nasal Polyps Treatment Market Size by Country (2016-2021)
6.4.2 North America Nasal Polyps Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Nasal Polyps Treatment Market Size (2016-2027)
7.2 Europe Nasal Polyps Treatment Market Size by Type
7.2.1 Europe Nasal Polyps Treatment Market Size by Type (2016-2021)
7.2.2 Europe Nasal Polyps Treatment Market Size by Type (2022-2027)
7.2.3 Europe Nasal Polyps Treatment Market Size by Type (2016-2027)
7.3 Europe Nasal Polyps Treatment Market Size by Application
7.3.1 Europe Nasal Polyps Treatment Market Size by Application (2016-2021)
7.3.2 Europe Nasal Polyps Treatment Market Size by Application (2022-2027)
7.3.3 Europe Nasal Polyps Treatment Market Size by Application (2016-2027)
7.4 Europe Nasal Polyps Treatment Market Size by Country
7.4.1 Europe Nasal Polyps Treatment Market Size by Country (2016-2021)
7.4.2 Europe Nasal Polyps Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Nasal Polyps Treatment Market Size (2016-2027)
8.2 Asia-Pacific Nasal Polyps Treatment Market Size by Type
8.2.1 Asia-Pacific Nasal Polyps Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Nasal Polyps Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Nasal Polyps Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Nasal Polyps Treatment Market Size by Application
8.3.1 Asia-Pacific Nasal Polyps Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Nasal Polyps Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Nasal Polyps Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Nasal Polyps Treatment Market Size by Region
8.4.1 Asia-Pacific Nasal Polyps Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Nasal Polyps Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Nasal Polyps Treatment Market Size (2016-2027)
9.2 Latin America Nasal Polyps Treatment Market Size by Type
9.2.1 Latin America Nasal Polyps Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Nasal Polyps Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Nasal Polyps Treatment Market Size by Type (2016-2027)
9.3 Latin America Nasal Polyps Treatment Market Size by Application
9.3.1 Latin America Nasal Polyps Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Nasal Polyps Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Nasal Polyps Treatment Market Size by Application (2016-2027)
9.4 Latin America Nasal Polyps Treatment Market Size by Country
9.4.1 Latin America Nasal Polyps Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Nasal Polyps Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Nasal Polyps Treatment Market Size (2016-2027)
10.2 Middle East & Africa Nasal Polyps Treatment Market Size by Type
10.2.1 Middle East & Africa Nasal Polyps Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Nasal Polyps Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Nasal Polyps Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Nasal Polyps Treatment Market Size by Application
10.3.1 Middle East & Africa Nasal Polyps Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Nasal Polyps Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Nasal Polyps Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Nasal Polyps Treatment Market Size by Country
10.4.1 Middle East & Africa Nasal Polyps Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Nasal Polyps Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 OptiNose US
11.1.1 OptiNose US Company Details
11.1.2 OptiNose US Business Overview
11.1.3 OptiNose US Nasal Polyps Treatment Introduction
11.1.4 OptiNose US Revenue in Nasal Polyps Treatment Business (2016-2021)
11.1.5 OptiNose US Recent Development
11.2 Regeneron Pharmaceuticals
11.2.1 Regeneron Pharmaceuticals Company Details
11.2.2 Regeneron Pharmaceuticals Business Overview
11.2.3 Regeneron Pharmaceuticals Nasal Polyps Treatment Introduction
11.2.4 Regeneron Pharmaceuticals Revenue in Nasal Polyps Treatment Business (2016-2021)
11.2.5 Regeneron Pharmaceuticals Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Nasal Polyps Treatment Introduction
11.3.4 Merck Revenue in Nasal Polyps Treatment Business (2016-2021)
11.3.5 Merck Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Nasal Polyps Treatment Introduction
11.4.4 Pfizer Revenue in Nasal Polyps Treatment Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 F. Hoffmann La-Roche
11.5.1 F. Hoffmann La-Roche Company Details
11.5.2 F. Hoffmann La-Roche Business Overview
11.5.3 F. Hoffmann La-Roche Nasal Polyps Treatment Introduction
11.5.4 F. Hoffmann La-Roche Revenue in Nasal Polyps Treatment Business (2016-2021)
11.5.5 F. Hoffmann La-Roche Recent Development
11.6 Intersect ENT
11.6.1 Intersect ENT Company Details
11.6.2 Intersect ENT Business Overview
11.6.3 Intersect ENT Nasal Polyps Treatment Introduction
11.6.4 Intersect ENT Revenue in Nasal Polyps Treatment Business (2016-2021)
11.6.5 Intersect ENT Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Nasal Polyps Treatment Introduction
11.7.4 GlaxoSmithKline Revenue in Nasal Polyps Treatment Business (2016-2021)
11.7.5 GlaxoSmithKline Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Nasal Polyps Treatment Introduction
11.8.4 Sanofi Revenue in Nasal Polyps Treatment Business (2016-2021)
11.8.5 Sanofi Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Nasal Polyps Treatment Introduction
11.9.4 Novartis Revenue in Nasal Polyps Treatment Business (2016-2021)
11.9.5 Novartis Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Nasal Polyps Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Pharmacological Therapies
Table 3. Key Players of Surgeries
Table 4. Global Nasal Polyps Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Nasal Polyps Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Nasal Polyps Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Nasal Polyps Treatment Market Share by Regions (2016-2021)
Table 8. Global Nasal Polyps Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Nasal Polyps Treatment Market Share by Regions (2022-2027)
Table 10. Nasal Polyps Treatment Market Trends
Table 11. Nasal Polyps Treatment Market Drivers
Table 12. Nasal Polyps Treatment Market Challenges
Table 13. Nasal Polyps Treatment Market Restraints
Table 14. Global Nasal Polyps Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Nasal Polyps Treatment Market Share by Players (2016-2021)
Table 16. Global Top Nasal Polyps Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nasal Polyps Treatment as of 2020)
Table 17. Ranking of Global Top Nasal Polyps Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Nasal Polyps Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Nasal Polyps Treatment Product Solution and Service
Table 21. Date of Enter into Nasal Polyps Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Nasal Polyps Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Nasal Polyps Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Nasal Polyps Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Nasal Polyps Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Nasal Polyps Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Nasal Polyps Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Nasal Polyps Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Nasal Polyps Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Nasal Polyps Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Nasal Polyps Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Nasal Polyps Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Nasal Polyps Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Nasal Polyps Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Nasal Polyps Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Nasal Polyps Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Nasal Polyps Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Nasal Polyps Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Nasal Polyps Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Nasal Polyps Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Nasal Polyps Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Nasal Polyps Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Nasal Polyps Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Nasal Polyps Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Nasal Polyps Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Nasal Polyps Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Nasal Polyps Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Nasal Polyps Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Nasal Polyps Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Nasal Polyps Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Nasal Polyps Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Nasal Polyps Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Nasal Polyps Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Nasal Polyps Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Nasal Polyps Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Nasal Polyps Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Nasal Polyps Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Nasal Polyps Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Nasal Polyps Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. OptiNose US Company Details
Table 62. OptiNose US Business Overview
Table 63. OptiNose US Nasal Polyps Treatment Product
Table 64. OptiNose US Revenue in Nasal Polyps Treatment Business (2016-2021) & (US$ Million)
Table 65. OptiNose US Recent Development
Table 66. Regeneron Pharmaceuticals Company Details
Table 67. Regeneron Pharmaceuticals Business Overview
Table 68. Regeneron Pharmaceuticals Nasal Polyps Treatment Product
Table 69. Regeneron Pharmaceuticals Revenue in Nasal Polyps Treatment Business (2016-2021) & (US$ Million)
Table 70. Regeneron Pharmaceuticals Recent Development
Table 71. Merck Company Details
Table 72. Merck Business Overview
Table 73. Merck Nasal Polyps Treatment Product
Table 74. Merck Revenue in Nasal Polyps Treatment Business (2016-2021) & (US$ Million)
Table 75. Merck Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Nasal Polyps Treatment Product
Table 79. Pfizer Revenue in Nasal Polyps Treatment Business (2016-2021) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. F. Hoffmann La-Roche Company Details
Table 82. F. Hoffmann La-Roche Business Overview
Table 83. F. Hoffmann La-Roche Nasal Polyps Treatment Product
Table 84. F. Hoffmann La-Roche Revenue in Nasal Polyps Treatment Business (2016-2021) & (US$ Million)
Table 85. F. Hoffmann La-Roche Recent Development
Table 86. Intersect ENT Company Details
Table 87. Intersect ENT Business Overview
Table 88. Intersect ENT Nasal Polyps Treatment Product
Table 89. Intersect ENT Revenue in Nasal Polyps Treatment Business (2016-2021) & (US$ Million)
Table 90. Intersect ENT Recent Development
Table 91. GlaxoSmithKline Company Details
Table 92. GlaxoSmithKline Business Overview
Table 93. GlaxoSmithKline Nasal Polyps Treatment Product
Table 94. GlaxoSmithKline Revenue in Nasal Polyps Treatment Business (2016-2021) & (US$ Million)
Table 95. GlaxoSmithKline Recent Development
Table 96. Sanofi Company Details
Table 97. Sanofi Business Overview
Table 98. Sanofi Revenue in Nasal Polyps Treatment Business (2016-2021) & (US$ Million)
Table 99. Sanofi Recent Development
Table 100. Novartis Company Details
Table 101. Novartis Business Overview
Table 102. Novartis Nasal Polyps Treatment Product
Table 103. Novartis Revenue in Nasal Polyps Treatment Business (2016-2021) & (US$ Million)
Table 104. Novartis Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nasal Polyps Treatment Market Share by Type: 2020 VS 2027
Figure 2. Pharmacological Therapies Features
Figure 3. Surgeries Features
Figure 4. Global Nasal Polyps Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Ambulatory Surgical Centers Case Studies
Figure 7. Specialty Clinics Case Studies
Figure 8. Nasal Polyps Treatment Report Years Considered
Figure 9. Global Nasal Polyps Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Nasal Polyps Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Nasal Polyps Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Nasal Polyps Treatment Market Share by Regions (2022-2027)
Figure 13. Global Nasal Polyps Treatment Market Share by Players in 2020
Figure 14. Global Top Nasal Polyps Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nasal Polyps Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Nasal Polyps Treatment Revenue in 2020
Figure 16. Global Nasal Polyps Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Nasal Polyps Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Nasal Polyps Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Nasal Polyps Treatment Market Share by Type (2016-2027)
Figure 20. North America Nasal Polyps Treatment Market Share by Application (2016-2027)
Figure 21. North America Nasal Polyps Treatment Market Share by Country (2016-2027)
Figure 22. United States Nasal Polyps Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Nasal Polyps Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Nasal Polyps Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Nasal Polyps Treatment Market Share by Type (2016-2027)
Figure 26. Europe Nasal Polyps Treatment Market Share by Application (2016-2027)
Figure 27. Europe Nasal Polyps Treatment Market Share by Country (2016-2027)
Figure 28. Germany Nasal Polyps Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Nasal Polyps Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Nasal Polyps Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Nasal Polyps Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Nasal Polyps Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Nasal Polyps Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Nasal Polyps Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Nasal Polyps Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Nasal Polyps Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Nasal Polyps Treatment Market Share by Region (2016-2027)
Figure 38. China Nasal Polyps Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Nasal Polyps Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Nasal Polyps Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Nasal Polyps Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Nasal Polyps Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Nasal Polyps Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Nasal Polyps Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Nasal Polyps Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Nasal Polyps Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Nasal Polyps Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Nasal Polyps Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Nasal Polyps Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Nasal Polyps Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Nasal Polyps Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Nasal Polyps Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Nasal Polyps Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Nasal Polyps Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Nasal Polyps Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Nasal Polyps Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. OptiNose US Revenue Growth Rate in Nasal Polyps Treatment Business (2016-2021)
Figure 58. Regeneron Pharmaceuticals Revenue Growth Rate in Nasal Polyps Treatment Business (2016-2021)
Figure 59. Merck Revenue Growth Rate in Nasal Polyps Treatment Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Nasal Polyps Treatment Business (2016-2021)
Figure 61. F. Hoffmann La-Roche Revenue Growth Rate in Nasal Polyps Treatment Business (2016-2021)
Figure 62. Intersect ENT Revenue Growth Rate in Nasal Polyps Treatment Business (2016-2021)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Nasal Polyps Treatment Business (2016-2021)
Figure 64. Sanofi Revenue Growth Rate in Nasal Polyps Treatment Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Nasal Polyps Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

以下、関連資料のご紹介

世界の副鼻腔炎治療薬市場規模・現状・予測（2021年-2027年）

Global Sinusitis Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-6007 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、副鼻腔炎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、NSAIDS、充血除去剤・粘液溶解剤、鼻洗浄キット）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界のフォン・ヴィレブランド病治療市場規模・現状・予測（2021年-2027年）

Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5033 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、フォン・ヴィレブランド病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（Veyvondi、Humate-P、Alphanate、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模...

世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年）

Global Hepatorenal Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4305 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、肝腎症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヘパトレン、テルリバズ、グリプレシン、ルカシン、その他）、用途別市場規模（1型肝腎症候群、2型肝腎症候群）、主要地域別市場規模（北米、アメ...

世界のアルギニン血症治療市場規模・現状・予測（2021年-2027年）

Global Argininemia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3852 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アルギニン血症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の痙性斜頸治療市場規模・現状・予測（2021年-2027年）

Global Cervical Dystonia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5653 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、痙性斜頸治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ボツリヌス菌、抗コリン作用薬、ドーパミン作動薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（...

世界の多汗症治療市場規模・現状・予測（2021年-2027年）

Global Hyperhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4337 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、多汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（投薬、外科治療、理学療法、その他）、用途別市場規模（病院、皮膚科、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界の家族性大腸腺腫症治療市場規模・現状・予測（2021年-2027年）

Global Familial Adenomatous Polyposis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5736 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、家族性大腸腺腫症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（イコサペント、塩酸エフロルニチン、アスピリン、CEQ-508、その他）、用途別市場規模（診療所、病院、その他）、主要地域別市場規模（...

世界のバッテン病治療市場規模・現状・予測（2021年-2027年）

Global Batten Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3891 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、バッテン病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（作業療法、理学療法）、用途別市場規模（乳児NCL、後期乳児NCL、少年NCL、成人NCL）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

鼻ポリープ治療のグローバル市場：規模・現状・予測2019-2025 In 2018, the global Nasal Polyps Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Nasal Polyps Treatment status, future forecast, growth opportunity, key market and key playe…
鼻ポリープ治療のグローバル市場：規模・現状・予測2019-2025 In 2018, the global Nasal Polyps Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Nasal Polyps Treatment status, future forecast, growth opportunity, key market and key playe…
鼻ポリープ薬のグローバル市場：規模・現状・予測2019-2025 Nasal polyps (NP) are noncancerous growths within the nose or sinuses. Symptoms include trouble breathing through the nose, loss of smell, decreased taste, post nasal drip, and a runny nose. The growths are sac-like, movable, and nontender, though face pain may occasionally occur. They typically occ…
鼻ポリープ薬のグローバル市場：規模・現状・予測2019-2025 Nasal polyps (NP) are noncancerous growths within the nose or sinuses. Symptoms include trouble breathing through the nose, loss of smell, decreased taste, post nasal drip, and a runny nose. The growths are sac-like, movable, and nontender, though face pain may occasionally occur. They typically occ…
世界の副腎脊髄神経障害治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Adrenomyeloneuropathy Treatment Market The global Adrenomyeloneuropathy Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data i…